In clinical trials, AbbVie's risankizumab-rzaa produced high rates of durable skin clearance – most people (82 and 81%) treated with the drug achieved 90% skin clearance (PASI 90) at 1 year, with the majority (56 and 60%) achieving complete skin clearance (PASI 100).
Top news of the day from across the health care landscape.
Research investigates whether statins are safe and effective for patients with inflammatory conditions, such as rheumatoid arthritis.
The potential for prescription drugs to cost more than $1 million for a treatment regimen creates a mixed bag of conundrums for the health care system.
With measles cases on the rise globally and with an outbreak of measles in communities right here in the United States, adults should ensure they are adequately vaccinated against this serious and potentially fatal disease.
Research investigates cytomegalovirus to understand the process of targeting HIV in order to eradicate it from the body.
Top news of the day from across the health care landscape.
Some patients reportedly opt not to seek medical care, because of a lack of empathy and understanding care providers about their needs.
Report shows that salaries were either flat or declining for most of the surveyed physicians.
The Center for Medicare and Medicaid Innovation (CMMI) will be inviting primary care practices to participate in 5 new alternative payment models that will allow primary care practices to provide new types of services to their patients that are not supported by current Medicare payments.
Pembrolizumab (Keytruda, Merck) has received FDA approval as a first-line treatment in combination with axitinib (Inlyta) for patients with advanced renal cell carcinoma (RCC), making it the first indication for pembrolizumab in this patient population.
This is the first indication for pembrolizumab (Keytruda, Merck) in advanced renal cell carcinoma.
In rare cases, patients with HIV can experience a paradoxical response to antiretroviral therapy known as extreme immune decline.
Precancerous cervical lesions, known as high-grade cervical lesions (CIN2+) can develop a few years after infection and have been used to monitor human papillomavirus (HPV) vaccine impact since cancers can take decades to develop.
What is causing KS's blood pressure to increase, despite maintaining a similar routine?
Top news of the day from across the health care landscape.
This approval marks the first generic naloxone nasal spray for use in a community setting by an individual without medical training.
This approval marks the first generic naloxone nasal spray for use in a community setting by an individual without medical training.
Spring cleaning brings the opportunity to clean out unused and unwanted medicines that collect over time, just like old clothes from the closet or old food from the fridge.
Sobetirome was shown to stimulate myelination in mice without the severe adverse effects commonly associated with thyroid hormone therapy for multiple sclerosis.
Top news of the week from Specialty Pharmacy Times.
Top news of the day from across the health care landscape.
Many health care professionals are being targeted by criminals, according to the DEA.
Study shows the importance of screening and treatment for depression, especially among patients with HIV since there has been an increase in life expectancy due to antiretroviral therapy.
Top news of the day from across the health care landscape.
Failure to understand and appreciate the dynamics of the marketplace is costing pharmacy owners money.
Those who qualify and complete our survey are eligible to enter our drawing in which 1 lucky winner will receive a $250 American Express gift card.
The commercial availability of Bijuva offers an FDA approved alternative to marketed synthetic hormones or individual estrogen and progesterone products that have not been FDA-approved for combination use.
Antioxidants can be used to improve certain health conditions.
Alisha Barr, PharmD, asked her fellow pharmacist moms to donate supplies to her brother, who is deployed in Syria, and was overwhelmed by the response.